Expression and clinical significance of the CD47/SIRPα pathway as a candidate immunotherapy target in non-small cell lung cancer (NSCLC)

被引:0
|
作者
Desai, Shruti [1 ]
Villarroel-Espindola, Franz [1 ]
Gaule, Patricia [1 ]
Ducler, Adam [1 ]
Peluso, Marisa [2 ]
Lee, Benjamin [2 ]
Schalper, Kurt [1 ]
Holland, Pamela [2 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Surface Oncol, Cambridge, MA USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P270
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
    Giatromanolaki, Alexandra
    Mitrakas, Achilleas
    Anestopoulos, Ioannis
    Kontosis, Andreas
    Koukourakis, Ioannis M.
    Pappa, Aglaia
    Panayiotidis, Mihalis I.
    Koukourakis, Michael I.
    CANCERS, 2022, 14 (07)
  • [2] CD47 is a promising therapeutic target in non-small cell lung cancer
    Lau, Asa P.
    Kubli, Shawn P.
    Wakeham, Andrew
    Mak, Tak W.
    Thu, Kelsie L.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
    Jia, Xiao
    Yan, Bingjun
    Tian, Xiaoqing
    Liu, Qian
    Jin, Jianhua
    Shi, Juanjuan
    Hou, Yongzhong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (13): : 3281 - 3287
  • [4] Myeloid cell contexture and IL-8 expression as a candidate immunotherapy target in non-small cell lung cancer (NSCLC)
    Nagineni, Venkata Vamsi
    Schalper, Kurt
    Desai, Shruti
    Melero, Ignacio
    Sanmamed, Miguel
    Gupta, Richa
    Herbst, Roy
    Nagineni, Venkata Vamsi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] CD47 Promotes Migration and Metastasis in Non-Small Cell Lung Cancer
    Lau, A. P.
    Hoshi, R.
    Rousseau, Z.
    Wu, Y. F.
    Ni, H.
    Thu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S301 - S301
  • [6] Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer
    Arrieta, Oscar
    Aviles-Salas, Alejandro
    Orozco-Morales, Mario
    Hernandez-Pedro, Norma
    Cardona, Andres F.
    Cabrera-Miranda, Luis
    Barrios-Bernal, Pedro
    Soca-Chafre, Giovanny
    Cruz-Rico, Graciela
    de Lourdes Pena-Torres, Maria
    Moncada-Claudio, Guadalupe
    Ramirez-Tirado, Laura-Alejandra
    CANCER MEDICINE, 2020, 9 (07): : 2390 - 2402
  • [7] Clinical significance of p-AKT pathway in non-small cell lung cancer (NSCLC)
    Yoshizawa, A.
    Fukuoka, J.
    Shilo, K.
    Franks, T. J.
    Hewitt, S. M.
    Fujii, T.
    Jen, J.
    Travis, W. D.
    Cordon-Cardo, C.
    MODERN PATHOLOGY, 2007, 20 : 335A - 335A
  • [8] Clinical significance of p-AKT pathway in non-small cell lung cancer (NSCLC)
    Yoshizawa, A.
    Fukuoka, J.
    Shilo, A.
    Franks, T. J.
    Hewitt, S. M.
    Fujii, T.
    Jen, J.
    Travis, W. D.
    Conlon-Cardo, C.
    LABORATORY INVESTIGATION, 2007, 87 : 335A - 335A
  • [9] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [10] CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
    Hui Zhao
    Jianxin Wang
    Xiaodan Kong
    Encheng Li
    Yuanbin Liu
    Xiaohui Du
    Zhijie Kang
    Ying Tang
    Yanbin Kuang
    Zhihui Yang
    Youwen Zhou
    Qi Wang
    Scientific Reports, 6